Trial intelligence / Profile preview

Psychophysiology of Prolonged Exposure for PTSD With/Without Yohimbine

NCT01031979Phase 2Completed

Sponsor
VA Office of Research & Development
Start
Dec 2010
Primary completion
Apr 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of yohimbine in post-traumatic stress disorder (PTSD), sponsored by VA Office of Research & Development. Started Dec 2010; status: completed.

02

Drugs

yohimbine
03

Conditions

post-traumatic stress disorder (PTSD)

Beyond the preview

Go deeper on NCT01031979.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01031979.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call